RETRACTED: Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells via Targeting STAT3 Signaling Pathway

Lou, Chenghua; Chen, Yan; Zhang, Jie; Yang, Bo; Zhao, Huajun

doi:10.3389/fphar.2019.01071

ORIGINAL RESEARCH article

Front. Pharmacol., 19 September 2019

Sec. Pharmacology of Anti-Cancer Drugs

Volume 10 - 2019 | https://doi.org/10.3389/fphar.2019.01071

RETRACTED: Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells via Targeting STAT3 Signaling Pathway

Retracted

A retraction of this article was approved in:

Retraction: Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells via Targeting STAT3 Signaling Pathway
1. Read retraction

Chenghua Lou^1†

Yan Chen^1†

Jie Zhang²

Bo Yang^1*

Huajun Zhao^1*

¹School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China
²Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, United States

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Lou C, Chen Y, Zhang J, Yang B and Zhao H (2019) Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells via Targeting STAT3 Signaling Pathway. Front. Pharmacol. 10:1071. doi: 10.3389/fphar.2019.01071

Received: 09 May 2019; Accepted: 22 August 2019;
Published: 19 September 2019; Retracted: 11 June 2025.

Edited by:

Cyril Corbet, Catholic University of Louvain, Belgium

Reviewed by:

Liang-Chuan Lai, National Taiwan University, Taiwan
Feng Gao, Washington University in St. Louis, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.